FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
8,278 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Sodium Phenylacetate and Sodium Benzoate | Sodium phenylacetate 100 mg/mL; Sodium benzoate 100 mg/mL | InjectionIntravenous | FOSUN PHARMA USA INC | NDA | 72266-236 | 72266-0236-01 | — |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | Sodium phenylacetate 100 mg/mL; Sodium benzoate 100 mg/mL | Injection, Solution, ConcentrateIntravenous | Omnivium Pharmaceuticals LLC | ANDA | 81665-203 | 81665-0203-01 | — |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | Sodium phenylacetate 100 mg/mL; Sodium benzoate 100 mg/mL | Injection, Solution, ConcentrateIntravenous | Omnivium Pharmaceuticals LLC | ANDA | 81665-204 | 81665-0204-01 | — |
| Sodium Phenylbutyrate | Sodium phenylbutyrate .94 g/g |
| PowderOral |
| Par Health USA, LLC |
| ANDA |
| 49884-006 |
| 49884-0006-04 |
| — |
| Sodium Phenylbutyratesodium phenylbutyrate tablets, 500 mg | Sodium phenylbutyrate 500 mg/1 | TabletOral | Par Health USA, LLC | ANDA | 49884-170 | 49884-0170-04 | — |
|---|
| sodium phenylbutyrate | Sodium phenylbutyrate 500 mg/1 | TabletOral | GLENMARK PHARMACEUTICALS INC., USA | ANDA | 68462-853 | 68462-0853-20 | — |
|---|
| Sodium phenylbutyrate | Sodium phenylbutyrate 500 mg/1 | TabletOral | Navinta LLC | ANDA | 68475-011 | 68475-0011-01 | — |
|---|
| Sodium phenylbutyrate | Sodium phenylbutyrate 500 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | ANDA | 70710-2180 | 70710-2180-08 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | NDA | 0409-7391 | 00409-7391-72 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | ANDA | 0517-7305 | 00517-7305-25 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | ANDA | 0517-7315 | 00517-7315-25 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | American Regent, Inc. | ANDA | 0517-7350 | 00517-7350-25 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | Unapproved drug (other) | 63323-170 | 63323-0170-0563323-0170-15 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-881 | 63323-0881-16 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-884 | 63323-0884-06 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-886 | 63323-0886-56 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | ANDA | 65145-200 | 65145-0200-25 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | ANDA | 65145-201 | 65145-0201-25 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | ANDA | 65145-202 | 65145-0202-25 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | ANDA | 68462-728 | 68462-0728-25 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | ANDA | 68462-729 | 68462-0729-25 | — |
|---|
| Sodium Phosphates | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Heptahydrate 268 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | ANDA | 68462-730 | 68462-0730-25 | — |
|---|
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | Civica, Inc. | ANDA | 72572-309 | 72572-0309-25 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 1 g/g | PowderOral, Rectal | KVK-Tech, Inc. | ANDA | 10702-036 | 10702-0036-1510702-0036-45 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | SUNRISE PHARMACEUTICAL, INC. | ANDA | 11534-166 | 11534-0166-1511534-0166-1611534-0166-44 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral | ATLANTIC BIOLOGICALS CORP. | ANDA | 17856-0024 | 17856-0024-0117856-0024-02 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral | PuraCap Laboratories, LLC | ANDA | 24658-760 | 24658-0760-16 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 15 g/60mL | SuspensionOral, Rectal | Burel Pharmaceuticals, LLC | ANDA | 35573-108 | 35573-0108-1435573-0108-57 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral | Epic Pharma, LLC | ANDA | 42806-013 | 42806-0013-9442806-0013-96 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 15 g/60mL | SuspensionOral, Rectal | CMP Pharma, Inc. | ANDA | 46287-006 | 46287-0006-0146287-0006-0446287-0006-60 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 1 g/g | Powder, For suspensionOral, Rectal | CMP Pharma, Inc. | ANDA | 46287-012 | 46287-0012-16 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 15 g/60mL | SuspensionOral, Rectal | Cardinal Health 107, LLC | ANDA | 55154-7353 | 55154-7353-02 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Chartwell RX, LLC | ANDA | 62135-340 | 62135-0340-1162135-0340-5362135-0340-62 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | ANDA | 63629-2390 | 63629-2390-01 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | ANDA | 63629-8849 | 63629-8849-01 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | ANDA | 63629-8850 | 63629-8850-01 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | ANDA | 71335-2855 | 71335-2855-01 | — |
|---|
| Sodium Polystyrene Sulfonate | Sodium polystyrene sulfonate 4.1 meq/g | Powder, For suspensionOral, Rectal | Bryant Ranch Prepack | ANDA | 72162-1230 | 72162-1230-0272162-1230-07 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | LiquidTopical | Laser Pharmaceuticals, LLC | Unapproved drug (other) | 16477-410 | 16477-0410-0616477-0410-12 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | ShampooTopical | Laser Pharmaceuticals, LLC | Unapproved drug (other) | 16477-411 | 16477-0411-08 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | LiquidTopical | Acella Pharmaceuticals, LLC | Unapproved drug (other) | 42192-129 | 42192-0129-16 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | ShampooTopical | BioComp Pharma, Inc. | Unapproved drug (other) | 44523-510 | 44523-0510-08 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | LiquidTopical | BioComp Pharma, Inc. | Unapproved drug (other) | 44523-606 | 44523-0606-1244523-0606-16 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | LiquidTopical | BioComp Pharma, Inc. | Unapproved drug (other) | 44523-613 | 44523-0613-06 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/g | LiquidTopical | Method Pharmaceuticals, LLC | Unapproved drug (other) | 58657-477 | 58657-0477-0658657-0477-1258657-0477-16 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/g | LiquidTopical | Bryant Ranch Prepack | Unapproved drug (other) | 63629-9262 | 63629-9262-01 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/g | LiquidTopical | Bryant Ranch Prepack | Unapproved drug (other) | 63629-9263 | 63629-9263-01 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/g | LiquidTopical | Bryant Ranch Prepack | Unapproved drug (other) | 63629-9264 | 63629-9264-01 | — |
|---|
| Sodium sulfacetamide | Sulfacetamide sodium 100 mg/mL | LotionTopical | Oceanside Pharmaceuticals | NDA authorized generic | 68682-010 | 68682-0010-04 | — |
|---|
| Sodium Sulfacetamide | Sulfacetamide sodium 100 mg/mL | LiquidTopical | Akron Pharma Inc | Unapproved drug (other) | 71399-0480 | 71399-0480-0271399-0480-0671399-0480-08 | — |
|---|